At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.
Funding
Late Stage
Current Stage
$228.59M
Total Funding
Recent News
Study: Cytovale’s Rapid Sepsis Test Helps Increase Safe ED Discharges
Medical Product Outsourcing
Cytovale · 6d ago
Director, Business Development - MidAtlantic Region
Maryland, United StatesHybridDirector/Executive
Cytovale · 1w ago
Sales Development Representative
South San Francisco, California, United StatesHybridEntry Level
Cytovale · 1m ago
Director, Financial Planning & Analysis
South San Francisco, California, United StatesOnsiteDirector/Executive
Cytovale · 3m ago
Marketing Specialist - Demand Generation
South San Francisco, California, United StatesRemoteMid, Senior Level